ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...
(RTTNews) - Abbott (ABT) has received FDA clearance for its Alinity m STI Assay test, which simultaneously detects and differentiates four common sexually transmitted infections. The Alinity m STI ...
More than 250 HPV tests and hundreds of different variants are commercially available globally, but majority of these tests do not meet the performance characteristic standards agreed upon in the HPV ...
Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) are found in high global seroprevalence. Infections usually are asymptomatic or manifest as mild or subclinical disease in immunocompetent ...
Credit: Getty Images. The Alinity m STI Assay uses in vitro RT-PCR technology with high sensitivity to detect and differentiate STIs from symptomatic and asymptomatic individuals. The Food and Drug ...
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Abbott Labs said its new "Alinity m" molecular laboratory ...
According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...
Abbott has received US Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results